Able 0 4 0 4 O
to 5 7 5 7 O
receive 8 15 8 15 O
weekly 16 22 16 22 O
food 23 27 23 27 O
shipments 28 37 28 37 O
delivered 38 47 38 47 O
every 48 53 48 53 O
Friday 54 60 54 60 O
for 61 64 61 64 O
6 65 66 65 66 B-upper_bound
weeks 67 72 67 72 I-upper_bound

Access 0 6 73 79 B-technology_access
to 7 9 80 82 I-technology_access
a 10 11 83 84 I-technology_access
computer 12 20 85 93 I-technology_access
with 21 25 94 98 I-technology_access
internet 26 34 99 107 I-technology_access
and 35 38 108 111 O
the 39 42 112 115 O
ability 43 50 116 123 O
to 51 53 124 126 O
complete 54 62 127 135 O
daily 63 68 136 141 O
online 69 75 142 148 O
surveys 76 83 149 156 O

Age 0 3 157 160 B-age
≥18 4 7 161 164 O

Albumin<2.0mg 0 13 165 178 B-clinical_variable
/ 13 14 178 179 I-upper_bound
dl 14 16 179 181 I-upper_bound
, 16 17 181 182 O
within 18 24 183 189 O
4 25 26 190 191 B-upper_bound
weeks 27 32 192 197 I-upper_bound
of 33 35 198 200 O
screening 36 45 201 210 O
( 46 47 211 212 O
if 47 49 212 214 O
tested 50 56 215 221 O
as 57 59 222 224 O
part 60 64 225 229 O
of 65 67 230 232 O
routine 68 75 233 240 O
clinical 76 84 241 249 O
care 85 89 250 254 O
) 89 90 254 255 O

BMI 0 3 256 259 B-bmi
< 4 5 260 261 O
16 5 7 261 263 B-upper_bound

BMI 0 3 264 267 B-bmi
≥40 4 7 268 271 O

Baseline 0 8 272 280 B-clinical_variable
stool 9 14 281 286 I-clinical_variable
frequency 15 24 287 296 I-clinical_variable
> 25 26 297 298 O
4 26 27 298 299 B-lower_bound
bowel 28 33 300 305 O
movements 34 43 306 315 O
/ 43 44 315 316 O
day 44 47 316 319 O
when 48 52 320 324 O
well 53 57 325 329 O

Celiac 0 6 330 336 B-chronic_disease
disease 7 14 337 344 I-chronic_disease

Currently 0 9 345 354 O
participating 10 23 355 368 O
in 24 26 369 371 O
another 27 34 372 379 B-treatment
clinical 35 43 380 388 I-treatment
trial 44 49 389 394 I-treatment
of 50 52 395 397 O
a 53 54 398 399 O
drug 55 59 400 404 O
to 60 62 405 407 O
treat 63 68 408 413 O
IBD 69 72 414 417 B-chronic_disease
or 73 75 418 420 O
a 76 77 421 422 O
dietary 78 85 423 430 B-treatment
therapy 86 93 431 438 I-treatment
for 94 97 439 442 O
any 98 101 443 446 O
indication 102 112 447 457 O

Diabetes 0 8 458 466 B-chronic_disease
Mellitus 9 17 467 475 I-chronic_disease
requiring 18 27 476 485 O
medication 28 38 486 496 O

Documented 0 10 497 507 O
diagnosis 11 20 508 517 O
of 21 23 518 520 O
Crohn 24 29 521 526 B-chronic_disease
's 29 31 526 528 I-chronic_disease
disease 32 39 529 536 I-chronic_disease

Known 0 5 537 542 O
allergy 6 13 543 550 O
to 14 16 551 553 O
tree 17 21 554 558 B-allergy_name
nuts 22 26 559 563 I-allergy_name
or 27 29 564 566 O
peanuts 30 37 567 574 B-allergy_name

Patients 0 8 575 583 O
may 9 12 584 587 O
continue 13 21 588 596 O
these 22 27 597 602 O
medications 28 39 603 614 O
at 40 42 615 617 O
stable 43 49 618 624 O
dose 50 54 625 629 O
for 55 58 630 633 O
the 59 62 634 637 O
first 63 68 638 643 O
six 69 72 644 647 B-upper_bound
weeks 73 78 648 653 I-upper_bound
and 79 82 654 657 O
budesonide 83 93 658 668 B-treatment
may 94 97 669 672 O
be 98 100 673 675 O
used 101 105 676 680 O
at 106 108 681 683 O
any 109 112 684 687 O
dose 113 117 688 692 O

Presence 0 8 693 701 O
of 9 11 702 704 O
an 12 14 705 707 O
ostomy 15 21 708 714 B-treatment

Start 0 5 715 720 O
or 6 8 721 723 O
change 9 15 724 730 O
dose 16 20 731 735 B-clinical_variable
of 21 23 736 738 O
corticosteroids 24 39 739 754 B-treatment
within 40 46 755 761 O
1 47 48 762 763 B-upper_bound
week 49 53 764 768 I-upper_bound
of 54 56 769 771 O
screening 57 66 772 781 O
or 67 69 782 784 O
a 70 71 785 786 O
dose 72 76 787 791 O
> 77 78 792 793 O
20mg 78 82 793 797 B-lower_bound
/ 82 83 797 798 I-lower_bound
day 83 86 798 801 I-lower_bound
prednisone 87 97 802 812 B-treatment
or 98 100 813 815 O
equivalent 101 111 816 826 B-treatment

Start 0 5 827 832 O
or 6 8 833 835 O
change 9 15 836 842 O
in 16 18 843 845 O
dose 19 23 846 850 O
of 24 26 851 853 O
any 27 30 854 857 O
5 31 32 858 859 B-treatment
- 32 33 859 860 I-treatment
ASA 33 36 860 863 I-treatment
medications 37 48 864 875 O
within 49 55 876 882 O
2 56 57 883 884 B-upper_bound
weeks 58 63 885 890 I-upper_bound
of 64 66 891 893 O
screening 67 76 894 903 O

Start 0 5 904 909 O
or 6 8 910 912 O
change 9 15 913 919 O
* 15 16 919 920 O
* 16 17 920 921 O
* 17 18 921 922 O
dose 19 23 923 927 O
of 24 26 928 930 O
anti 27 31 931 935 O
- 31 32 935 936 O
TNF 32 35 936 939 O
agents 36 42 940 946 O
( 43 44 947 948 O
including 44 53 948 957 O
infliximab 54 64 958 968 B-treatment
( 65 66 969 970 I-treatment
Remicade 66 74 970 978 I-treatment
) 74 75 978 979 I-treatment
, 75 76 979 980 O
adalimumab 77 87 981 991 B-treatment
( 88 89 992 993 I-treatment
Humira 89 95 993 999 I-treatment
) 95 96 999 1000 I-treatment
, 96 97 1000 1001 O
certolizumab 98 110 1002 1014 B-treatment
pegol 111 116 1015 1020 I-treatment
( 117 118 1021 1022 I-treatment
Cimzia 118 124 1022 1028 I-treatment
) 124 125 1028 1029 I-treatment
, 125 126 1029 1030 O
golimumab 127 136 1031 1040 B-treatment
( 137 138 1041 1042 I-treatment
Simponi 138 145 1042 1049 I-treatment
) 145 146 1049 1050 I-treatment
or 147 149 1051 1053 O
ustekinumab 150 161 1054 1065 B-treatment
within 162 168 1066 1072 O
8 169 170 1073 1074 B-upper_bound
weeks 171 176 1075 1080 I-upper_bound
prior 177 182 1081 1086 I-upper_bound
to 183 185 1087 1089 O
screening 186 195 1090 1099 O

Start 0 5 1100 1105 O
or 6 8 1106 1108 O
change 9 15 1109 1115 O
* 15 16 1115 1116 O
* 16 17 1116 1117 O
* 17 18 1117 1118 O
dose 19 23 1119 1123 O
of 24 26 1124 1126 O
thiopurines 27 38 1127 1138 B-treatment
( 39 40 1139 1140 O
azathioprine 40 52 1140 1152 B-treatment
and 53 56 1153 1156 O
6 57 58 1157 1158 B-treatment
- 58 59 1158 1159 I-treatment
MP 59 61 1159 1161 I-treatment
) 61 62 1161 1162 O
, 62 63 1162 1163 O
methotrexate 64 76 1164 1176 B-treatment
, 76 77 1176 1177 O
natalizumab 78 89 1178 1189 B-treatment
, 89 90 1189 1190 O
or 91 93 1191 1193 O
vedolizumab 94 105 1194 1205 B-treatment
within 106 112 1206 1212 O
12 113 115 1213 1215 B-upper_bound
weeks 116 121 1216 1221 I-upper_bound
prior 122 127 1222 1227 I-upper_bound
to 128 130 1228 1230 O
screening 131 140 1231 1240 O

Use 0 3 1241 1244 O
of 4 6 1245 1247 O
antibiotics 7 18 1248 1259 B-treatment
( 19 20 1260 1261 O
other 20 25 1261 1266 O
than 26 30 1267 1271 O
topical 31 38 1272 1279 O
formulations 39 51 1280 1292 O
) 51 52 1292 1293 O
for 53 56 1294 1297 O
any 57 60 1298 1301 O
reason 61 67 1302 1308 O
within 68 74 1309 1315 O
2 75 76 1316 1317 B-upper_bound
weeks 77 82 1318 1323 I-upper_bound
prior 83 88 1324 1329 I-upper_bound
to 89 91 1330 1332 O
screening 92 101 1333 1342 O

